Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Trovagene’s PCM-075 therapy for several blood cancers and solid tumors, including colon cancer, proved safe in a Phase 1 clinical trial. The results of the trail conducted by Nerviano Medical ... Read more
The higher intake of animal fat and meat among African-Americans is a potential environmental risk factor for colorectal cancer, as it changes to composition of their gut microbiota, according to results ... Read more
The likelihood of having an inherited gene mutation linked to colorectal cancer may be higher than previously believed, according to researchers from the Dana-Farber Cancer Institute. In a study of ... Read more
Researchers identified two biomarkers that predict whether patients with colorectal carcinoma will respond well to treatment with Erbitux (cetuximab) or the chemotherapy agent 5FU, according to a new study. These ... Read more
An inflammatory protein called MMP9 may protect against the development of colitis-associated cancer (CAC), a type of colorectal cancer associated with chronic inflammatory diseases, a new study says. The study, ... Read more
A preclinical study showed that response of colorectal cancer to treatment can be detected after a single administration using the diagnostic agent TumorVue (99mTc-duramycin), developed by Molecular Targeting Technologies (MTTI). These ... Read more
Primary tumor resection (surgical removal of the original tumor) does not improve survival compared with chemotherapy in patients with metastatic colon cancer, according to the results of an observational cohort ... Read more